| Regenea Quick, | |
|
20 Hospital Dr, Logan, WV 25601-3452 | |
| (304) 831-1891 | |
| (304) 831-1892 |
| Full Name | Regenea Quick |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 20 Hospital Dr, Logan, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134724826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | 58649 (West Virginia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 107920 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Medical Center | Logan, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Logan General Hospital Llc | 9537078977 | 24 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
Amneal Pharmaceuticals LLC will launch its AB-rated generic for Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg, 75 mg the first week of January 2014.
› Verified 2 days ago
| Entity Name | Logan General Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720032105 PECOS PAC ID: 9537078977 Enrollment ID: O20031217001124 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
Amneal Pharmaceuticals LLC will launch its AB-rated generic for Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg, 75 mg the first week of January 2014.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Regenea Quick, 20 Hospital Dr, Logan, WV 25601-3452 Ph: (304) 831-1891 | Regenea Quick, 20 Hospital Dr, Logan, WV 25601-3452 Ph: (304) 831-1891 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that a medicinal chemistry paper related to the discovery of CUDC-101, Curis's HDAC, EGFR and Her2 inhibitor, was published online in the Journal of Medicinal Chemistry and also will be published in an upcoming print version of the journal.
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced the company's new focused RNAi therapeutic strategy at the Jefferies 2010 Global Life Sciences Conference.
ERA-NET PathoGenoMics, an initiative of the European Commission aimed at advancing transnational genome-based research programs on human-pathogenic microorganisms, announced today the third international joint call. The third joint call allocated €8.5 Million over 3 years to relevant research projects which will be provided by ERA-NET PathoGenoMics partner organizations from Austria, France, Germany, Hungary, Israel, Portugal, Slovenia and Spain.
Amneal Pharmaceuticals LLC will launch its AB-rated generic for Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg, 75 mg the first week of January 2014.
› Verified 2 days ago
Timothy M Reed, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1188 | |
Mrs. Amber Ellis, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 140 Stollings Ave, Suite 3, Logan, WV 25601 Phone: 304-752-4594 | |
Jenna Marie Hager, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 77 Hospital Dr, Logan, WV 25601 Phone: 304-896-5200 Fax: 304-896-5300 | |
William Ray Watkins Jr., RN, MSN, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 214 Hanging Rock Hwy, Logan, WV 25601 Phone: 304-784-5404 | |
Takara Leeann Muncy, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 174 Lmah Center Rd, Logan, WV 25601 Phone: 304-792-7130 Fax: 304-792-7146 | |
Mr. Printess John Lawrence, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Prosperity Lane, Suite 100, Logan, WV 25601 Phone: 304-831-0073 Fax: 304-831-0471 | |
Patsy Eugenie Stoots, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20 Hospital Dr, Logan, WV 25601 Phone: 304-831-1101 |